The utilization of patient-derived organoids as a platform for predicting the efficacy of anti-cancer drugs: Chemotherapy, targeted therapy, and immunotherapy.

Authors: Ji Yeon Lee, Misun Park, Yunjee Kim, Jieun Sung, Jinguen Rheey, Ji-Yeon Park

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15102

Source: Full article

---

Abstract

e15102